Clinical Trial Update: Effects of Sitagliptin in Individuals With Genetically Decreased DPP4 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of sitagliptin in individuals with genetically decreased DPP4, including participants with type 2 diabetes and hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Genetics Disease, Type2 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING